Dr Michael L Lunn, DO | |
10240 Park Meadows Dr, Lone Tree, CO 80124-5425 | |
(303) 338-4545 | |
Not Available |
Full Name | Dr Michael L Lunn |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 10240 Park Meadows Dr, Lone Tree, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780890178 | NPI | - | NPPES |
69265500 | Medicaid | CO | |
027143 | Other | CO | KAISER COMMERCIAL NUMBER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 2229 (Maine) | Secondary |
208000000X | Pediatrics | OT011240 (Pennsylvania) | Secondary |
207K00000X | Allergy & Immunology | 0056905 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Michael L Lunn, DO 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: () - | Dr Michael L Lunn, DO 10240 Park Meadows Dr, Lone Tree, CO 80124-5425 Ph: (303) 338-4545 |
News Archive
Aeterna Zentaris Inc. earlier today, presented positive final Phase 2 efficacy and safety data for its targeted cytotoxic luteinizing hormone releasing hormone (LHRH) analog, AEZS-108, in advanced endometrial cancer.
Defined sets of factors can reprogram human cells to induced pluripotent stem cells. However, many types of human cells are not easily accessible to minimally invasive procedures. In a paper published in the International and American Associations for Dental Research's Journal of Dental Research, lead researcher K. Tezuka and researchers N. Tamaoki, H. Aoki, T. Takeda-Kawaguchi, K. Iida, T. Kunisada and T. Shibata all from the Gifu University Graduate School of Medicine, Japan; and K. Takahashi, T. Tanaka and S. Yamanaka, all from Kyoto University, Japan, evaluate dental pulp cells as an optimal source of iPS cells, since they are easily obtained from extracted teeth and can be expanded under simple culture conditions.
Aradigm Corporation today announced that the first patient was dosed in a 6-month, multicenter, international Phase 2 clinical trial of a novel version of inhaled ciprofloxacin (ARD-3150) in 40 adult patients with non-cystic fibrosis bronchiectasis.
AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced the recent filing of a patent for its newly launched ChronoSil polymer product, a silicone-urethane copolymer. This patent application relates to silicone-urethane copolymers and methods for making ChronoSil.
› Verified 4 days ago
Sanford Eldon Avner, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 10099 Ridgegate Pkwy, Ste. #400, Lone Tree, CO 80124 Phone: 303-706-9923 Fax: 303-706-0904 | |
Dr. Jayna Doshi, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 10240 Park Meadows Dr, Lone Tree, CO 80124 Phone: 303-338-4545 |